Back to Search Start Over

Leishmaniasis and Autoimmunity in Patient with LPS-Responsive Beige-Like Anchor Protein (LRBA) Deficiency

Authors :
Mohammad Shahrooei
Asghar Aghamohammadi
Reza Yazdani
Hassan Abolhassani
Afshin Shirkani
Fereshte Salami
Gholamreza Azizi
Source :
Endocrine, Metabolic & Immune Disorders - Drug Targets. 20:479-484
Publication Year :
2020
Publisher :
Bentham Science Publishers Ltd., 2020.

Abstract

Background/Objective: LPS-responsive beige-like anchor protein (LRBA) deficiency is a combined immunodeficiency and immune dysregulation. The authors present a case report of LPSresponsive beige-like anchor protein (LRBA) deficiency with the history of autoimmunity, enteropathy and visceral leishmaniasis. Sirolimus therapy was started for autoimmunity and enteropathy but was discontinued due to recurrent leishmaniasis. Therefore, a common side-effect of many immunosuppressive drugs in patients with LRBA deficiency is increased susceptibility to infections. Methods: Whole exome sequencing was performed to detect the underlying genetic mutation and Leishmania DNA was detected by the PCR technique in this patient. Results: Whole exome sequencing of the patient reported a homozygous frameshift deletion mutation in the LRBA gene (NM_006726: exon29: c.4638delC, p. S1546fs). Leishmania DNA PCR was positive in this case. Conclusion: Parasite infections manifestations report in LRBA deficiency. Leishmania infections in patients with chronic diarrhea and autoimmunity should be considered for immunodeficiency.

Details

ISSN :
18715303
Volume :
20
Database :
OpenAIRE
Journal :
Endocrine, Metabolic & Immune Disorders - Drug Targets
Accession number :
edsair.doi.dedup.....2f3773a785a141995dc10ab200852697
Full Text :
https://doi.org/10.2174/1871530319666190807161546